ABO-incompatible kidney transplantation in elderly patients over 60 years of age

International Urology and Nephrology

Volumn 44, Issue 5, 2012, Pages 1563-1570

  Uchida, Junji ^a   Iwai, Tomoaki ^a   MacHida, Yuichi ^a   Kuwabara, Nobuyuki ^a   Kabei, Kazuya ^a   Murao, Masaki ^a   Otoshi, Taiyo ^a   Naganuma, Toshihide ^a   Kumada, Norihiko ^a   Nakatani, Tatsuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ABOincompatible; Desensitization protocol; Elderly patients; Kidney transplantation

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS; VIRUS ANTIGEN;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CASE REPORT; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DESENSITIZATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVING DONOR; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PLASMAPHERESIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; SINGLE DRUG DOSE; SPLENECTOMY; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS REACTIVATION;

ABO BLOOD-GROUP SYSTEM; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BLOOD GROUP INCOMPATIBILITY; CYTOMEGALOVIRUS; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; JAPAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; NEUTROPENIA; PLASMA EXCHANGE; PLASMAPHERESIS; SPLENECTOMY; TRANSPLANTS; VIRUS ACTIVATION;

EID: 84867888492     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0231-z     Document Type: Article

References (16)

1. Danovitch G, Savransky E (2006) Challenges in the counseling and management of older kidney transplant candidates. Am J Kidney Dis 47:S86-S97
2. Collins AJ, Foley RN, Herzog C et al (2011) US renal data system 2010 annual data report. Am J Kidney Dis 57(A8):e1-e526
3. Cameron JI, Whiteside C, Katz J, Devins GM (2000) Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis 35:629-637
4. Oniscu GC, Brown H, Forsythe JL (2004) How old is old for transplantation? Am J Transpl 4:2067-2074
5. Takahashi K, Saito K, Takahara S et al (2004) Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transpl 4:1089-1096
6. Uchida J, Kuwabara N, Machida Y et al (2012) Excellent outcomes of ABO-incompatible kidney transplantation: a single-center experience. Transpl Proc 44:204-209
7. Uchida J, Machida Y, Iwai T et al (2011) Clinical outcome of ABO-incompatible living unrelated donor kidney transplantation. Urol Int 86:307-314
8. Uchida J, Machida Y, Iwai T et al (2010) Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation. Transpl Proc 42:3998-4002
9. Uchida J, Iwai T, Kato M et al (2008) A novel approach to successful ABO-incompatible high-titer renal transplantation. Transpl Proc 40:2285-2288
10. Wolfe RA, Ashby VB, Milford EL et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis waiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725-1730
11. Gill JS, Tonelli M, Johnson N et al (2005) The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int 68:2345-2351
12. Cooper M, Forland CL (2011) The elderly as recipients of living donor kidneys, how old is too old? Curr Opin Organ Transpl 16:250-255
13. Gill J, Bunnapradist S, Danovitch GM et al (2008) Outcomes of kidney transplantation from older living donors to older recipients. Am J Kidney Dis 52:541-552
14. Cornella C, Brustia M, Lazzarich E et al (2008) Quality of life in renal transplant patients over 60 years of age. Transpl Proc 40:1865-1866
15. Kuypers DR (2009) Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Drugs Aging 26:715-737
16. Stegall MD, Dean PG, Gloor JM (2004) ABO-incompatible kidney transplantation. Transplantation 78:635-640